Due to the COVID-19 pandemic, BCBSRI has extended all clinical authorization approvals by Prime Ther...

Effective 1 de mayo de 2020, Lifespan employee group will begin covering medical specialty drugs under the...

As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...

As part of the annual formulary development and management process, the next scheduled update of the...

As part of our standard formulary management process of implementing formulary updates twice per yea...

Effective 1 de diciembre de 2019, BCBSRI will begin requiring prior authorization for an expanded list of ...

As of 1 de octubre de 2019, for commercial members, the drugs listed below will move from the specialty p...

Effective 1 de julio de 2019, both PCSK-9 products for cholesterol management—Repatha and Praluent—became ...

Pharmacy benefit coverage for Commercial members will be updated effective 1 de mayo de 2019 to include co...

The BCBSRI Commercial formulary for April is now available. You can view the summary that provides d...

Consistent with our management practice, 1 de abril de 2019 is the next scheduled update of the BCBSRI Co...

Effective 1 de abril de 2019, coverage of Radicava will change from the specialty pharmacy benefit to the...

In order to meet these deadlines, all relevant clinical information must be provided at the time a d...

BCBSRI is informing the provider community about a recent CMS guideline change regarding opioid use ...

In our ongoing efforts to make high-quality and affordable healthcare available to our members, BCBS...

Consistent with our management practice, 1 de octubre de 2018 marked the next scheduled update of the BCB...

Effective 1 de octubre de 2018, the BCBSRI Pharmacy Formulary will be updated to remove the generic equiv...